Investigating the effect of transcendental meditation on blood pressure: a systematic review and meta-analysis.
Z Bai, J Chang, C Chen, P Li, K Yang, I Chi
Journal of human hypertension November 1, 2015 DOI: 10.1038/jhh.2015.6 (opens in new tab) via PubMed
Summary
AI-generated from the abstractA systematic review and meta-analysis of twelve randomized controlled trials with 996 participants found that transcendental meditation (TM) reduced systolic blood pressure by approximately 4.26 mm Hg and diastolic blood pressure by about 2.33 mm Hg compared with control groups. Subgroup analyses suggested TM had a greater effect on systolic blood pressure among older participants, those with higher initial blood pressure, and women. For diastolic blood pressure, TM appeared more effective in short-term interventions and among individuals with higher blood pressure. The authors note that biases, including lack of information about study design and blood pressure measurement methods, may have influenced the results.
Study at a glance
| Characteristics | Systematic review and meta-analysis Randomized Peer reviewed |
|---|---|
| Sample size | 996 |
| Population | Participants from randomized controlled trials of transcendental meditation for blood pressure |
| Intervention | Transcendental meditation |
| Key finding | Transcendental meditation reduced systolic blood pressure by approximately 4.26 mm Hg and diastolic by 2.33 mm Hg compared with controls, with greater effects in certain subgroups. |
Abstract
Some evidence from previous randomized controlled trials and systematic reviews has demonstrated a positive association between hypertension and transcendental meditation (TM). However, other trials and reviews showed the effect of TM on blood pressure (BP) was unclear but did not use subgroup analysis to rigorously investigate this relationship. The American Heart Association has stated that TM is potentially beneficial but did not give a standard indication. The present study explored several subgroup analyses in systematic reviews to investigate the effect of TM on BP. Medline, Embase, Cochrane Library, Web of Science and Chinese BioMedical Literature Database were searched through August 2014. Randomized controlled trials of TM as a primary intervention for BP were included. Two reviewers independently used the Cochrane Collaboration's quality assessment tool to assess each study's quality. Twelve studies with 996 participants indicated an approximate reduction of systolic and diastolic BP of -4.26 mm Hg (95% CI=-6.06, -2.23) and -2.33 mm Hg (95% CI=-3.70, -0.97), respectively, in TM groups compared with control groups. Results from subgroup analysis suggested that TM had a greater effect on systolic BP among older participants, those with higher initial BP levels, and women, respectively. In terms of diastolic BP, it appears that TM might be more efficient in a short-term intervention and with individuals experiencing higher BP levels. However, some biases may have influenced the results, primarily a lack of information about study design and methods of BP measurement in primary studies.